Treatment of Candida albicans with sublethal concentration of keanumycin A
Ontology highlight
ABSTRACT: To determine the potential mode of action of the new antifungal compound candidate keanumycin A, the C. albicans wild type SC5314 was exposed to a sublethal dose of the substance. Untreated samples serve as control.
INSTRUMENT(S): GenePix 4000B
ORGANISM(S): Candida albicans
SUBMITTER: Sascha Brunke
PROVIDER: E-MTAB-12311 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA